Sildenafil cost: what to expect, and how to evaluate any quote
What we evaluated: publicly advertised pricing for Sildenafil across telehealth and longevity providers
Date verified: July 12, 2026
Direct answer: Both tadalafil and sildenafil are FDA-approved and available as inexpensive generics. For most patients the right move is to price the plain generic at a local or mail-order pharmacy before paying a telehealth subscription — and certainly before paying for a compounded troche or 'proprietary blend', which is not FDA-approved and has no demonstrated advantage over the generic.
Necessary qualification: A telehealth platform can still be worth paying for if you want the consultation and the convenience. It is not worth paying for as a way to buy a worse-regulated version of a cheap, approved drug.
Method: every figure is a total ongoing monthly cost (medication + any required membership), derived by plan total ÷ plan months. See our pricing-verification methodology.
How Sildenafil differs from the alternatives
What makes sildenafil different from tadalafil. Sildenafil is the shorter-acting drug: a half-life of about 4 hours and an effective window of 4-6 hours, against tadalafil's 36.
That is not automatically worse, and for some men it is better. (1) Shorter exposure, shorter side effects. If you get headache or flushing, they clear faster. (2) It is the oldest and most-studied PDE5 inhibitor, with the longest post-marketing safety record of any drug in this class. (3) It is usually the cheapest generic.
The trade-offs are real. Food matters: a high-fat meal delays and blunts absorption, so sildenafil is best taken on a relatively empty stomach — a genuine planning constraint that tadalafil does not impose. No daily option and no BPH indication: if you have prostate symptoms as well as ED, tadalafil treats both and sildenafil does not. And the characteristic visual side effect — a transient blue tinge to vision — is a sildenafil phenomenon, related to PDE6 cross-reactivity in the retina.
Cost
How to evaluate any quote you are given
Since we will not hand you a number we cannot stand behind, the useful thing we can give you is the method. Every quote in this category should be normalised the same way we normalise GLP-1 pricing.
| Ask for… | Because… |
|---|---|
| The total monthly cost, including every fee | Split billing — medication plus a membership — is the commonest way a price looks lower than it is |
| The ongoing price, not the first month | Introductory rates are customer-acquisition pricing. You pay the ongoing rate for eleven of twelve months |
| Whether the price rises with dose | A programme that is cheapest at the starting dose can be the most expensive at maintenance |
| What happens if you cancel early | On a committed plan this is the question most likely to cost you money, and the one most often skipped |
| Whether labs, shipping and visits are included | 'All-inclusive' is used loosely. Test it against specifics rather than accepting the phrase |
| The annual total | Monthly figures are how this is marketed. Annual totals are how it is actually experienced |
Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.
Why we publish no number here, when every competitor does
Search this treatment and you will find a dozen pages confidently quoting a monthly price. We could do the same in five minutes. We have not, and the reason is worth stating because it is the whole difference between this site and those.
A price is a claim about the world. To publish one responsibly you need to have captured it — from the provider's own page, on a stated date, with the fee structure, the commitment, the dose ceiling and the cancellation terms attached. Anything less is repetition, and repetition is how the contradictory figures in this industry propagate: one site guesses, three copy it, and by the fourth it reads as consensus.
We have captured that evidence for GLP-1 pricing, which is why our GLP-1 pages carry dated figures and evidence labels. We have not captured it for this treatment. So we publish the method for evaluating a quote instead of a number we cannot defend — and when we do capture it, it will appear here with a source and a date.
We do not mark a price Verified merely because another comparison site published it. Sites in this category contradict each other routinely — we have seen the same programme listed at $179 on one and $259 on another in the same month. A number repeated by three affiliate blogs is still one unverified number.
What a commitment actually costs you
Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.
Questions to ask before you pay
Five questions, all answerable in writing before any money changes hands. Is the price you quoted the month-to-month rate, or does it require a prepaid term? Does it include every mandatory recurring fee, or is a membership billed separately?
Which pharmacy will fill the prescription, and is it a 503A compounding pharmacy or a 503B outsourcing facility? What is the concentration in the vial, since compounded preparations are not standardised between pharmacies and dosing instructions given in units or millilitres depend on it? And what happens if I cancel mid-term — what is refundable and what is not?
A programme that answers all five clearly has told you what you need. One that answers none of them has also told you something.
Questions to ask about the pharmacy
The pharmacy matters more than the telehealth brand on the front of the website. The telehealth company arranges the consultation; the pharmacy makes the medicine you inject.
- Which specific pharmacy will fill my prescription? Not "our network" — the name of the facility.
- Is it a 503A state-licensed pharmacy or a 503B FDA-registered outsourcing facility? These are different regulatory categories with different oversight, and a company can use both for different products.
- In which state is it licensed, and can I look up the licence? State boards of pharmacy publish licensee databases.
- What is the exact salt form and concentration? Semaglutide sodium and semaglutide acetate are not the same active ingredient as the semaglutide base in approved products, and the FDA has said they are not appropriate for compounding.
- Is the vial single-dose or multi-dose? A multi-dose vial requires you to measure each dose yourself, which is the most common source of the dosing errors behind reported adverse events.
- Will you provide a certificate of analysis?
- Has the pharmacy received any FDA warning letter or state board action?
A provider that answers all seven in writing is demonstrating something real. A provider that will not name its pharmacy has given you an answer, whether it intended to or not.
How to verify any of this yourself
You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.
- Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
- Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
- Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
- Ask what the highest dose costs. By email or chat, so you have it in writing.
- Ask about early cancellation before you commit to a plan longer than a month.
- Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.
If a provider will not answer questions 4 or 5 in writing, that is itself information.
The context that applies to this whole category
Three patterns recur across peptide and longevity marketing, and once you can name them you will see them everywhere.
Mouse-to-human transfer. A striking longevity or fat-loss result in mice is presented as though it applies to you. Mouse longevity findings have a long and well-documented history of not translating to humans.
Biomarker-for-outcome substitution. A study shows a blood level rose — NAD+, IGF-1, growth hormone — and the marketing implies you will therefore feel better, look better or live longer. Raising a biomarker is not the same as improving an outcome, and for most of these treatments the outcome studies simply have not been done.
Deficiency-to-enhancement transfer. A treatment that genuinely helps people with a diagnosed deficiency is sold to healthy people seeking optimisation. Tesamorelin works for HIV-associated lipodystrophy; that is not evidence that it works for a healthy 45-year-old who wants a flatter stomach.
None of these are valid inferences. All three are standard in this industry's marketing.
Frequently asked questions
What does Sildenafil cost?
Generic tadalafil and sildenafil are inexpensive and FDA-approved. Price the generic at a pharmacy before paying for a compounded version or a subscription.
Is Sildenafil covered by insurance?
Generic PDE5 inhibitors are often covered, though plans may restrict quantity. Ask the pharmacy for the cash price too — for generics it is sometimes lower than a copay.
How do I evaluate a quote?
Ask for the total monthly cost including every fee; whether the price rises with dose; what happens if you cancel; which pharmacy compounds it; and what the concentration is. A provider who will not answer in writing has told you something.
Sources
- U.S. Food and Drug Administration — approved labels and compounding guidance.
- PubMed / NIH — indexed clinical literature for this molecule.
- ClinicalTrials.gov — registered trials, where they exist.
- Our pricing-verification methodology.
- We do not cite affiliate comparison sites as evidence of price — see our source hierarchy.
The numbers behind this page
What we do not claim in this page
Every price quoted in this page comes from the programme's own pricing page and carries the date it was captured.
We do not claim these prices will hold. Compounded pricing moves within weeks, and a figure without a capture date is not a fact. We do not claim a compounded preparation is equivalent to an approved product: it is not FDA-approved, is not therapeutically equivalent to any brand-name product, and FDA does not review it for safety, effectiveness or manufacturing quality before marketing.
And we do not claim to be a clinical resource. Which molecule suits you, at what dose, and whether treatment is appropriate at all are questions for a prescribing clinician who has your history. This is price research, and it is only useful once those questions are settled.
Reading the price against the market
What the plan term is worth
The figures in this page sit inside a market with a measurable shape, and that shape is what makes any single price readable.
Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.
Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.
We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.
What the plan term is worth
The figures in this page sit inside a market with a measurable shape, and that shape is what makes any single price readable.
Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.
Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.
We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.
Questions this page answers
Are compounded GLP-1 medicines FDA-approved?
No. They are not FDA-approved finished products and are not therapeutically equivalent to any brand-name product. FDA does not review them for safety, effectiveness or manufacturing quality before marketing.
Why do the same programmes quote two different prices?
Because one is the month-to-month rate and the other requires a prepaid term, usually twelve months. We rank on the month-to-month figure and state the prepaid rate separately, since a rate requiring a year's commitment is not the same offer.
Where do these prices come from?
Each is read from the programme's own published pricing page and carries its capture date. The full set of 24 standard-dose records is at /api/prices.json with molecule and dose class on every record.
What is the cheapest verified GLP-1 programme?
Oak Longevity at $133 a month for semaglutide and Found at $169 for tirzepatide, both at standard therapeutic dosing.